» Articles » PMID: 39294184

Evaluation of Effectiveness and Safety of Subolesin Anti-tick Vaccine in Ugandan Multi-site Field Trial

Abstract

Vaccines are the most effective and sustainable intervention to control ticks and tick-borne diseases (TBD). Using a personalized vaccine design based on regional tick genotypes, a Rhipicephalus appendiculatus Subolesin protective antigen was used in a field trial evaluating tick vaccine efficacy, effectiveness, and safety in cattle infested with multiple tick species in different Ugandan agro-ecological zones. Vaccination with SUB was safe with a protective capacity against anemia and infection, and reduced the number of infested cattle, tick fitness (feeding and reproduction) with vaccine effectiveness against multiple tick species between 93.2% at 167-196 days post-vaccination (dpv) and 61.4% at 251-327 dpv. Total integrated vaccine efficacy/effectiveness was estimated as 98.8%. The Subolesin-based vaccine is protective against multiple cattle tick infestations under field conditions in Uganda. These results support registration and commercialization of the vaccine to reduce tick populations and associated risks for human and animal TBD and chemical acaracides in Uganda.

Citing Articles

Haemaphysalis longicornis subolesin controls the infection and transmission of severe fever with thrombocytopenia syndrome virus.

Yuan C, Sun Y, Chen J, Xu Q, Zhou X, Zou Z NPJ Vaccines. 2025; 10(1):17.

PMID: 39856151 PMC: 11761454. DOI: 10.1038/s41541-024-01061-1.


Perspectives on using integrated tick management to control in a tropical region of Mexico.

Lagunes-Quintanilla R, Gomez-Romero N, Mendoza-Martinez N, Castro-Saines E, Galvan-Arellano D, Basurto-Alcantara F Front Vet Sci. 2024; 11:1497840.

PMID: 39649682 PMC: 11621215. DOI: 10.3389/fvets.2024.1497840.


Design and evaluation of vaccines for the control of the etiological agent of East Coast fever.

de la Fuente J, Sobrino I, Villar M Parasit Vectors. 2024; 17(1):479.

PMID: 39567980 PMC: 11580188. DOI: 10.1186/s13071-024-06517-w.


Overview of Recombinant Tick Vaccines and Perspectives on the Use of Plant-Made Vaccines to Control Ticks of Veterinary Importance.

Trujillo E, Ramos-Vega A, Monreal-Escalante E, Almazan C, Angulo C Vaccines (Basel). 2024; 12(10).

PMID: 39460344 PMC: 11512348. DOI: 10.3390/vaccines12101178.

References
1.
de la Fuente J, Estrada-Pena A . Why New Vaccines for the Control of Ectoparasite Vectors Have Not Been Registered and Commercialized?. Vaccines (Basel). 2019; 7(3). PMC: 6789832. DOI: 10.3390/vaccines7030075. View

2.
Olmeda A, Armstrong P, Rosenthal B, Valladares B, Del Castillo A, de Armas F . A subtropical case of human babesiosis. Acta Trop. 1997; 67(3):229-34. DOI: 10.1016/s0001-706x(97)00045-4. View

3.
Khorasani A, Madadgar O, Soleimanjahi H, Keyvanfar H, Mahravani H . Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle. Iran J Vet Res. 2016; 17(1):8-12. PMC: 4898013. View

4.
Willadsen P, Riding G, McKenna R, Kemp D, Tellam R, Nielsen J . Immunologic control of a parasitic arthropod. Identification of a protective antigen from Boophilus microplus. J Immunol. 1989; 143(4):1346-51. View

5.
Garcia-Garcia J, Montero C, Redondo M, Vargas M, Canales M, Boue O . Control of ticks resistant to immunization with Bm86 in cattle vaccinated with the recombinant antigen Bm95 isolated from the cattle tick, Boophilus microplus. Vaccine. 2000; 18(21):2275-87. DOI: 10.1016/s0264-410x(99)00548-4. View